por
Lauren Dubinsky, Senior Reporter | January 08, 2016
DF: In the health care policy space we tend to talk about reimbursement, but we discount the idea of the cost of the procedure to the provider and the price of the procedure to the patient or the insurance company.
I feel like over the next year or even a little bit longer, we're going to move a little bit away from reimbursement. It's still going to be important, but we're going to start talking more and more about cost and price in the marketplace.
Ad Statistics
Times Displayed: 7549
Times Visited: 112 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
I think that is appropriate because it's not about how much you get paid, it's really about how much it costs and what the patient is responsible for. Adding those two additional legs to the three-legged stool is a very important element in actually moving forward in the health care space from an economic perspective.
Back to HCB News
